Prostate Cancer Theranostics - An Overview

Diane Abou, Nadia Benabdallah, Wen Jiang, Lu Peng, Hanwen Zhang, Alexandria Villmer, Mark S. Longtine, Daniel L.J. Thorek

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


Metastatic prostate cancer is incurable, and novel methods to detect the disease earlier and to direct definitive treatment are needed. Molecularly specific tools to localize diagnostic and cytotoxic radionuclide payloads to cancer cells and the surrounding microenvironment are recognized as a critical component of new approaches to combat this disease. The implementation of theranostic approaches to characterize and personalize patient management is beginning to be realized for prostate cancer patients. This review article summarized clinically translated approaches to detect, characterize, and treat disease in this rapidly expanding field.

Original languageEnglish
Article number884
JournalFrontiers in Oncology
StatePublished - Jun 5 2020


  • alpha particle
  • peptide
  • prostate cancer
  • radionuclide
  • radiotherapy


Dive into the research topics of 'Prostate Cancer Theranostics - An Overview'. Together they form a unique fingerprint.

Cite this